COVID-19 and Global Chronic Disease 2024: The Post-pandemic Era
A special issue of Diseases (ISSN 2079-9721).
Deadline for manuscript submissions: 31 December 2024 | Viewed by 195
Special Issue Editors
Interests: nonalcoholic fatty liver disease; alcoholic liver disease; gut microbiota; Mediterranean diet; nutrition; COVID-19; probiotic
Special Issues, Collections and Topics in MDPI journals
2. Department of Medicine and Translational Surgery, Catholic University of Rome, 00153 Roma, Italy
Interests: imaging in lung cancer; imaging in pleural and mediastinal tumors; PET CT scan in thoracic neoplasms
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Coronavirus disease 2019 (COVID-19) is the condition caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since 2020, the pandemic has influenced our lives in nearly every corner of the world, causing over 770 million confirmed cases and more than 7 million deaths globally. This global scenario changed ways to perform research and consider healthcare systems. In fact, the COVID-19 crisis emphasized the connections between research, clinical practice, and health policies. On 5 May 2023, more than three years after the pandemic had been declared, the World Health Organization ended the global emergency status for COVID-19; however, the end of the pandemic will not be the end of COVID-19. It is necessary to continue protecting the most vulnerable people against the disease and its complications, through routine vaccination. In this way, many pivotal points are open and need to be clarified.
Aim and Scope
This Special Issue, titled “COVID-19 and Global Chronic Disease 2024: the Post-Pandemic era”, aims to report the state of the art and the new challenges resulting from COVID-19. In particular, we want to discuss the therapies, vaccines, public health policies, and social aspects related to this disease. We invite eminent scholars and emerging researchers to submit high-level scientific articles, as indicated in the keywords below.
Prof. Dr. Ludovico Abenavoli
Prof. Dr. Filippo Lococo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diseases is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pandemic
- COVID-19
- infection
- therapy
- disease
- health
- patients
- healthcare
- research
